Current trends in self-monitoring of glycemic levels

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Ensuring control of diabetes mellitus (DM) is impossible without self-monitoring by the patient, which does not lose its relevance in modern conditions. Recommendations for the management of diabetic patients are updated annually, more modern approaches to self-monitoring of glycemia are developed, innovative glucometers are introduced, including systems with a mobile application. The article presents innovative trends in glycemic monitoring using intelligent mobile applications that allow for more effective, including remote, DM management.

全文:

受限制的访问

作者简介

O. Koteshkova

Endocrinology Dispensary of the Moscow Healthcare Department

编辑信件的主要联系方式.
Email: koala58@mail.ru
ORCID iD: 0000-0001-8428-4116
SPIN 代码: 6141-1224

Cand. Sci. (Med.), Head of the Department of Diabetes Education and Treatment

俄罗斯联邦, Moscow

M. Antsiferov

Endocrinology Dispensary of the Moscow Healthcare Department; Russian Medical Academy of Continuous Professional Education

Email: koala58@mail.ru
ORCID iD: 0000-0002-9944-2997
SPIN 代码: 1035-4773
俄罗斯联邦, Moscow; Moscow

D. Antsiferova

Endocrinology Dispensary of the Moscow Healthcare Department; Russian Medical Academy of Continuous Professional Education

Email: koala58@mail.ru
ORCID iD: 0000-0002-3920-5914
俄罗斯联邦, Moscow; Moscow

参考

  1. www.diabetesatlas.org. Facts & figures (idf.org). URL: https://www.idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html.
  2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86. doi: 10.1056/NEJM199309303291401.
  3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53. doi: 10.1016/S0140-6736(98) 07019-6.
  4. Дедов И.И., Шестакова М.В., Майоров А.Ю. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. 11-е изд. М., 2023. [Dedov I.I., Shestakova M.V., Mayorov A.Yu. Algorithms of specialized medical care for patients with diabetes mellitus. 11th ed. M., 2023. (In Russ.)]. doi: 10.14341/DM13042.
  5. Nathan D.M., Cleary P.A., Backlund J.-Y.C., et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643–53. doi: 10.1056/NEJMoa052187.
  6. Patel A., MacMahon S., et al.; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–72 . doi: 10.1056/NEJMoa0802987.
  7. Duckworth W., Abraira C., Moritz T., et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129–39. doi: 10.1056/NEJMoa0808431.
  8. Gerstein H.C., Miller M.E., et al.; ACCORD Study Group. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med. 2011;364:818–28. doi: 10.1056/NEJMoa1006524.
  9. Russo G., Di Bartolo P., Candido R., et al. The AMD ANNALS: A continuous initiative for the improvement of type 2 diabetes care. Diab Res Clin Pract. 2023;199:110672. doi: 10.1016/j.diabres.2023.110672.
  10. Gagliardino J.J., Chantelot J.M., Domenger C., et al. Impact of diabetes education and self-management on the quality of care for people with type 1 diabetes mellitus in the Middle East (the International Diabetes Mellitus Practices Study, IDMPS). Diab Res Clin Pract. 2019;9(147):29–36. doi: 10.1016/j.diabres.2018.09.008.
  11. Grady M., Katz L.B., Cameron H., Levy B.L. Diabetes app-related text messages from health care professionals in conjunction with a new wireless glucose meter with a color range indicator improves glycemic control in patients with type 1 and type 2 diabetes: randomized controlled trial. JMIR Diabetes.2017;2(2):e19. doi: 10.2196/diabetes.7454.
  12. Pleus S., Freckmann G., Schauer S., et al. Self-monitoring of blood glucose as an integral part in the management of people with Type 2 Diabetes Mellitus. Diab Ther. 2022;13:829–46. doi: 10.1007/s13300-022-01254-8.
  13. Williams D.M., Parsons S.N., Dunseath G.J., et al. The impact of structured self-monitoring of blood glucose on glycaemic variability in non-insulin treated type 2 diabetes: The SMBG study, a 12-month randomised controlled trial. Diab Metab Syndr. 2020;14:101–6. doi: 10.1016/j.dsx.2020.01.006.
  14. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. 11-й выпуск. М., 2023. [Dedov I.I., Shestakova M.V., Mayorov A.Yu. Algorithms of specialized medical care for patients with diabetes mellitus. 11th ed. M., 2023. (In Russ.)].doi: 10.14341/DM13042.
  15. ElSayed N.A., Aleppo G., Aroda V.R., et al. 7. Diabetes Technology: Standards of Care in Diabetes-2023. Diab Care. 2023;46:111. doi: 10.2337/dc23-S007.
  16. IDF Diabetes Atlas, 10th Edition. Available at: https://diabetesatlas.org. Accessed 7th Jan, 2022.
  17. Polonsky W.H., Fisher L., Schikman C.H., et al. A structured self-monitoring of blood glucose approach in type 2 diabetes encourages more frequent, intensive, and effective physician interventions: results from the STeP study. Diab Technol Ther. 2011;13:797–802. doi: 10.1089/dia.2011.0073.
  18. Di Molfetta S., Bosi E., Ceriello A., et al. Structured self-monitoring of blood glucose is associated with more appropriate therapeutic interventions than unstructured self-monitoring: A novel analysis of data from the PRISMA trial. Diab Res Clin Pract. 2021;181:109070. doi: 10.1016/j.diabres.2021.109070.
  19. Battelino T., DanneT., Bergenstal R.M., et al. Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the International Consensus on Time in Range. Diab Care. 2019;42:1593–603. doi: 10.2337/dci19-0028.
  20. Russo G.T., Andreozzi F., Calabrese M., et al. Role of telemedicine during COVID-19 pandemic in type 2 diabetes outpatients: The AMD annals initiative. Diab Res Clin Pract. 2022;194:110158. doi: 10.1016/j.diabres.2022.110158.
  21. Verma D., Bahurupi Y., Kant R., et al. Effect of mHealth Interventions on Glycemic Control and HbA1c Improvement among Type II Diabetes patients in Asian population: A systematic review and meta-analysis. Indian J Endocrinol Metab. 2021;25:484–92. doi: 10.4103/ijem.ijem_387_21.
  22. Fisher L., Fortmann A., Stuhr A. Can a Basic Management App Paired With A Glucose Meter Help Reduce Glucose Levels Among Adults With Type 2 Diabetes? The REALL Study. J Diab Sci Technol. 2024;18(1):99–105. doi: 10.1177/19322968221096163.
  23. Steinhubl S.R., Muse E.D., Topol E.J. Can mobile health technologies transform health care? JAMA. 2013;310(22):2395–6. doi: 10.1001/jama.2013.281078.
  24. Garabedian L.F., Ross-Degnan D., Wharam J.F. Mobile phone and smartphone technologies for diabetes care and self-management. Curr Diab Rep. 2015;15(12):109. doi: 10.1007/s11892-015-0680-8.
  25. Vaala S.E., Hood K.K., Laffel L., et al. Use of commonly available technologies for diabetes information and self-management among adolescents with type 1 diabetes and their parents: a web-based survey study. Interact J Med Res. 2015;4(4):e24. doi: 10.2196/ijmr.4504.
  26. Liang X., Wang Q., Yang X., et al. Effect of mobile phone intervention for diabetes on glycaemic control: a meta-analysis. Diab Med. 2011;28(4):455–63. doi: 10.1111/j.1464-5491.2010.03180.x.
  27. Arambepola C., Ricci-Cabello I., Manikavasagam P., et al. The impact of automated brief messages promoting lifestyle changes delivered via mobile devices to people with type 2 diabetes: a systematic literature review and meta-analysis of controlled trials. J Med Internet Res. 2016;18(4):e86. doi: 10.2196/jmir.5425.
  28. Handa T., Onoue T., Kobayashi T., et al. Effects of Digitization of Self-Monitoring of Blood Glucose Records Using a Mobile App and the Cloud System on Outpatient Management of Diabetes: Single-Armed Prospective Study. JMIR. Diabetes. 2024;9:e48019. doi: 10.2196/48019.
  29. Bellfield E.J., Sharp L.K., Xia Y., Gerber B.S. Use of a mobile app to facilitate blood glucose monitoring in adolescents with type 1 diabetes: single-subject nonrandomized clinical trial. JMIR. Diabetes. 2018;3(1):e3. doi: 10.2196/diabetes.8357.
  30. Hao Y., Xu H. A prospective cohort study on the management of young patients with newly diagnosed type 2 diabetes using mobile medical applications. Diab Ther. 2018;9(5):2099–106. doi: 10.1007/s13300-018-0506-1.
  31. Дианов О.А., Майоров Р.В., Горшкова М.А., Колесникова Ю.В. Точность измерения и интерференция при самоконтроле гликемии с помощью глюкометра САТЕЛЛИТ® ONLINE у больных сахарным диабетом. Эффективная фармакотерапия. 2023;19(34):24–30. [Dianov O.A., Mayorov R.V., Gorshkova M.A., Kolesnikova Yu.V. Measurement Accuracy and Interference in Self-Monitoring of Glycemia with the SATELLITE® ONLINE Glucose Meter in Patients with Diabetes Mellitus. Effektivnaya farmakoterapiya. 2023;19(34):24–30. (In Russ.)]. doi: 10.33978/2307-3586-2023-19-34-24-30.

补充文件

附件文件
动作
1. JATS XML
2. Fig. 1. New communication strategy between patient and doctor

下载 (178KB)
3. Fig. 2. Harmonised error grid of capillary blood parameters when assessing the accuracy of Satellite® Online glucometer

下载 (122KB)
4. Fig. 3. Diagram of data transfer from Satellite® Online glucometer to the EMIAS system

下载 (177KB)
5. Fig. 4. Visualisation of Satellite® Online application data in the EMIAS system

下载 (163KB)

版权所有 © Bionika Media, 2024